Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

REVEALED: 45 - The Real Truth

Letters to The Editor — October 3, 2023

Readers’ mail to The Hindu’s Letters to The Editor

The Hindu

Johnson & Johnson not to enforce patents on TB drug

“The announcement will finally pave the way for unfettered access to affordable generic versions of bedaquiline for all people”

The Hindu

Have a complaint about CVS? So do pharmacists: Many just walked out

After a large walkout forced at least a dozen stores to shut down in the Kansas City area, CVS promises change. But critics say the crisis in staffing and unfair pay extends beyond that market.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Vivek Ramaswamy is furiously defending his business ties in China. What are they?

‘Vivek’s first business had a subsidiary in China’ which was closed ‘as the risks of doing business in China became apparent,’ Ramaswamy spokesperson says

The Independent UK

3 Biotech Stocks to Buy Instead of Palatin Technologies (PTN)

While Palatin Technologies (PTN) has faced challenges with declining share price, negative analyst projections, and limited profitability, it's worth noting the consistent growth in the broader biotech industry. Thus, investors could find more stable returns in robust biotech stocks Protalix BioTherapeutics (PLX), Exelixis (EXEL), and Jazz Pharmaceuticals (JAZZ) instead. Read…

StockNews.com

3 A-Rated Pharma Buys for October

The growing adoption of innovative drugs and the heightened demand for personalized medicines are expected to boost the pharma industry. Therefore, it might be wise to buy fundamentally strong pharma stocks Neurocrine Biosciences (NBIX), Novo Nordisk (NVO), and AstraZeneca PLC (AZN), which are rated an A (Strong Buy) in our…

StockNews.com

‘My posts are backed up with solid evidence, research’: Liver Doc on Himalaya Wellness suit

“Based on strong scientific evidence, or because of lack of it, I have been critical of several of Himalaya Wellness’ products,” said doctor-influencer Cyriac Abby Philips aka The Liver Doc, whose X account was suspended today for posting “defamatory remarks” against the ayurvedic pharma company.

Newslaundry

Read news from The Economist, FT, and more,
with one subscription

People with HIV offered hope of self-injected drug at home

GSK-controlled company works on developing patient-administered treatment by end of the decade

The Guardian - UK

Common children’s antibiotic amoxicillin still in short supply for the second year

While pharmacies say they can still fill most prescriptions for amoxicillin, the most-prescribed drug in the country, the shortage could worsen when the viral season hits this winter, experts say.

Chicago Sun-Times

New York drug consumption rooms to influence Glasgow pilot, First Minister says

GLASGOW’S pioneering drug consumption room will be shaped by research carried out in New York City, the First Minister has said.

The National (Scotland)

'Easier access': Oral contraceptives from pharmacies

'Recognition of the capabilities that pharmacies have.'

Newcastle Herald

The first OTC birth control is coming

An OTC birth control pill will help ensure more people can access the contraception they need without barriers

Salon

An overdose drug is finally over-the-counter. Is that enough to stop the death toll?

Narcan is now available in drug stores without a prescription. The nasal spray can save a life by stopping an opioid overdose. But will people pay the price and ask for it by name?

WEKU

Prescription pilot just the tonic for pharmacists

Pharmacists will be able to prescribe medications and administer more vaccines under a pilot program being expanded throughout Queensland.

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Draft patent amendment rules undermine pre-grant opposition

Draft patent rules threaten pre-grant opposition, a key public health safeguard. Big pharma seeks to remove essential safeguards from India’s patent laws, creating needless hurdles in pre-grant opposition. Draft rules introduce variable fees, power to determine maintainability of representation by individuals/groups. This threatens access to quality-assured, affordable generics & extends…

StockNews.com

Bionano Genomics (BNGO) Challengers: 3 Biotech Innovators to Buy Instead

With the rising aging population and the emergence of new diseases, the biotech industry appears poised for steady growth. Therefore, three quality biotech stocks, Vanda Pharmaceuticals (VNDA), Organogenesis Holdings (ORGO), and Exelixis (EXEL), could be better catches than Bionano Genomics (BNGO). Read on….

The Independent UK

Walgreens and CVS warned about selling illegal eye products

Warning letters sent to the companies claimed certain products they sell are ‘especially concerning from a public health perspective’

The Independent UK

Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm

Washington’s revolving door kept spinning this week as the Drug Enforcement Administration’s recently departed second-in-command returned for another stint with a high-powered consulting firm where he previously advised OxyContin maker Purdue Pharma

Get all your
news in one place.

100's of premium titles.
One news app.

Newsroom.co.nz

Workplace drug testing quagmire deepens

Medical cannabis is behind an uptick in workplace drug detection and the solution isn't clear-cut, reports Andrew Bevin

The Hindu

Xpert MTB/RIF molecular test for tuberculosis diagnosis to cost 20% less

Danaher Corporation, which sells the Xpert MTB/RIF molecular test for diagnosing tuberculosis (TB) and rifampicin resistance, has announced a lowering of the price of its standard TB test cartridge

StockNews.com

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

The National (Scotland)

Three Scottish cities to apply for drug testing facilities, says minister

APPLICATIONS will be made for drug testing facilities in three Scottish cities, drugs policy minister Elena Whitham has said...

StockNews.com

Is Palatin Technologies (PTN) Stock a Biotech Buy Before Earnings?

Palatin Technologies’ (PTN) stock has plummeted more than 75% over the past year. Since its inception, the biotech company has incurred massive net losses and negative cash flows from operations. Further, it anticipates incurring additional losses in the future. So, let’s determine if PTN is a buy or sell before…

The Independent UK

Expand pharmacy capabilities to ease pressure on GPs, think tanks say

The report outlined a number of recommendations for policymakers, as well as ‘significant’ barriers facing the sector.

StockNews.com

3 Healthcare Stocks to Buy Today

The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV).

1 … 44 45 46 47

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

the Chinese Communist Party

185 stories

Amgen

174 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.